Showing 121 to 132 of 171 results
mRNA Vaccine Shows Promise in Extending Survival for Early-Stage Pancreatic Cancer
A clinical trial at Memorial Sloan Kettering successfully used a customized mRNA vaccine alongside surgery and chemotherapy to treat early-stage pancreatic cancer, resulting in significantly extended survival time for eight of sixteen patients who showed strong immune responses and only two recurren...
mRNA Vaccine Shows Promise in Extending Survival for Early-Stage Pancreatic Cancer
A clinical trial at Memorial Sloan Kettering successfully used a customized mRNA vaccine alongside surgery and chemotherapy to treat early-stage pancreatic cancer, resulting in significantly extended survival time for eight of sixteen patients who showed strong immune responses and only two recurren...
Progress
40% Bias Score
18-Year Remission Achieved in Neuroblastoma Patient via CAR T-cell Therapy
An 18-year remission in a neuroblastoma patient treated with CAR T-cell therapy, a pioneering immunotherapy involving genetically modified T-cells, showcases its potential for long-term remission in solid tumors, particularly for childhood cancers.
18-Year Remission Achieved in Neuroblastoma Patient via CAR T-cell Therapy
An 18-year remission in a neuroblastoma patient treated with CAR T-cell therapy, a pioneering immunotherapy involving genetically modified T-cells, showcases its potential for long-term remission in solid tumors, particularly for childhood cancers.
Progress
40% Bias Score
Greece's Pediatric Cancer Survival Rate Soars to Over 85%
Greece's pediatric cancer survival rate is now over 85%, thanks to advancements in treatment, including cellular and gene therapies, transplants, and international collaborations; this progress is further solidified with the "Marianna V. Vardinoyianni" Oncology Unit becoming the "Elpida" oncology ho...
Greece's Pediatric Cancer Survival Rate Soars to Over 85%
Greece's pediatric cancer survival rate is now over 85%, thanks to advancements in treatment, including cellular and gene therapies, transplants, and international collaborations; this progress is further solidified with the "Marianna V. Vardinoyianni" Oncology Unit becoming the "Elpida" oncology ho...
Progress
44% Bias Score
Mum Funds Cancer Treatment Unapproved by NHS
A UK mother of two is fundraising for private chemosaturation treatment (£46,000 per round) for liver cancer after her ocular melanoma spread, as the NHS does not fund this treatment, despite Mayor Andy Burnham's offer to intervene.
Mum Funds Cancer Treatment Unapproved by NHS
A UK mother of two is fundraising for private chemosaturation treatment (£46,000 per round) for liver cancer after her ocular melanoma spread, as the NHS does not fund this treatment, despite Mayor Andy Burnham's offer to intervene.
Progress
48% Bias Score
Cancer Specialist's Diagnosis Highlights Advancements and Challenges in NHS Cancer Care
Professor Adrian Crellin, a 70-year-old cancer specialist, was diagnosed with prostate cancer in 2016 and is receiving treatment at the Bexley Wing in Leeds, highlighting the emotional challenges and advancements in NHS cancer care; prostate cancer cases in England increased by 25% since 2019.
Cancer Specialist's Diagnosis Highlights Advancements and Challenges in NHS Cancer Care
Professor Adrian Crellin, a 70-year-old cancer specialist, was diagnosed with prostate cancer in 2016 and is receiving treatment at the Bexley Wing in Leeds, highlighting the emotional challenges and advancements in NHS cancer care; prostate cancer cases in England increased by 25% since 2019.
Progress
40% Bias Score
Record High Cancer Survivor Rate in US, but Cardiovascular Risks Rise
The number of cancer survivors in the US exceeds 18 million, a record high due to early detection and effective treatments; however, these treatments can cause cardiovascular issues, leading to increased referrals to cardio-oncology clinics.
Record High Cancer Survivor Rate in US, but Cardiovascular Risks Rise
The number of cancer survivors in the US exceeds 18 million, a record high due to early detection and effective treatments; however, these treatments can cause cardiovascular issues, leading to increased referrals to cardio-oncology clinics.
Progress
28% Bias Score
19-Year Remission Achieved in Neuroblastoma Patient Treated with CAR-T Cells
A 4-year-old girl treated for neuroblastoma in 2006 at Texas Children's Hospital with experimental CAR-T cell therapy remains cancer-free 19 years later, representing the longest remission ever reported for this treatment and offering new hope for solid tumor therapies.
19-Year Remission Achieved in Neuroblastoma Patient Treated with CAR-T Cells
A 4-year-old girl treated for neuroblastoma in 2006 at Texas Children's Hospital with experimental CAR-T cell therapy remains cancer-free 19 years later, representing the longest remission ever reported for this treatment and offering new hope for solid tumor therapies.
Progress
48% Bias Score
Veteran's Cancer Remission Highlights Immunotherapy Success
U.S. Navy veteran John Ryan, diagnosed with stage 4 lung cancer in 2013, achieved remission after 100 months of immunotherapy treatment, highlighting the effectiveness of this approach and the increased cancer risk among veterans.
Veteran's Cancer Remission Highlights Immunotherapy Success
U.S. Navy veteran John Ryan, diagnosed with stage 4 lung cancer in 2013, achieved remission after 100 months of immunotherapy treatment, highlighting the effectiveness of this approach and the increased cancer risk among veterans.
Progress
40% Bias Score
Cancer Treatment Advancements Allow Fertility Preservation, But Raise New Challenges
Maggie Loucks, diagnosed with HER2-positive breast cancer at 28, chose a less aggressive chemotherapy regimen to preserve fertility, highlighting advancements in cancer treatment that prioritize quality of life alongside cancer survival, but also facing subsequent fertility challenges.
Cancer Treatment Advancements Allow Fertility Preservation, But Raise New Challenges
Maggie Loucks, diagnosed with HER2-positive breast cancer at 28, chose a less aggressive chemotherapy regimen to preserve fertility, highlighting advancements in cancer treatment that prioritize quality of life alongside cancer survival, but also facing subsequent fertility challenges.
Progress
40% Bias Score
Phase One Clinical Trial Begins for Novel Russian Oncolytic Virus Cocktail
The Herzen Institute in Moscow has begun phase one clinical trials of a new Russian-made oncolytic virus cocktail for breast cancer treatment, involving 38 patients and showing promise in pre-clinical trials, with plans to expand to glioblastoma and other cancer types in later phases.
Phase One Clinical Trial Begins for Novel Russian Oncolytic Virus Cocktail
The Herzen Institute in Moscow has begun phase one clinical trials of a new Russian-made oncolytic virus cocktail for breast cancer treatment, involving 38 patients and showing promise in pre-clinical trials, with plans to expand to glioblastoma and other cancer types in later phases.
Progress
56% Bias Score
Robotic Surgery Revolutionizes Urology: Advancements, Competition, and Future Trends
Spanish urologist Roberto Ballestero Diego discusses the evolution of surgical techniques, focusing on robotic surgery's impact on prostate cancer treatment, BPH management, and the emergence of new competitors in the surgical robotics market.
Robotic Surgery Revolutionizes Urology: Advancements, Competition, and Future Trends
Spanish urologist Roberto Ballestero Diego discusses the evolution of surgical techniques, focusing on robotic surgery's impact on prostate cancer treatment, BPH management, and the emergence of new competitors in the surgical robotics market.
Progress
52% Bias Score
German Teenager's Cancer Remission Highlights Innovative Treatment
A 16-year-old boy from near Darmstadt, Germany, successfully battled a recurring cancerous tumor above his left eye through an experimental treatment at the KiTZ Heidelberg, involving testing multiple drugs on mini-tumors derived from his tissue sample, resulting in remission.
German Teenager's Cancer Remission Highlights Innovative Treatment
A 16-year-old boy from near Darmstadt, Germany, successfully battled a recurring cancerous tumor above his left eye through an experimental treatment at the KiTZ Heidelberg, involving testing multiple drugs on mini-tumors derived from his tissue sample, resulting in remission.
Progress
36% Bias Score
Showing 121 to 132 of 171 results